-
Kidney Cancer Drugs Market to Reach $10.31 Billion by 2029 with 4.8% CAGR
10 Dec 2025 19:45 GMT
… modification of treatments, enhancement of treatment outcomes through personalised medicine, funding for … pharmacy corporation, Amneal Pharmaceuticals Inc. This drug, which is a … (UCC)
2) By Product: Nexavar (Sorafenib), Sutent (Sunitinib), Afinitor …
-
HLB liver cancer combo beats Nexavar in phase 3 with nearly 2-year survival
27 Nov 2025 08:14 GMT
… phase 3 trial testing camrelizumab plus rivoceranib against Bayer’s Nexavar (sorafenib … therapy, including immunotherapy and targeted drugs.
Median progression-free survival was … and 71 percent on sorafenib.
Treatment-related events were reported in …
-
<![CDATA[Insurance and Tolerability Factors Considered in Recurrent RCC Treatment]]>
21 Oct 2025 02:18 GMT
… on second-line treatment and beyond and … 3 trial [NCT02627963] vs sorafenib [Nexavar], and that trial required … Calithera Biosciences, Eisai Medical Research, ONO Pharmaceutical, Eli Lilly, Oncorena … #47;www.accessdata.fda.gov/drugsatfda_docs/label …
-
‘From Rs 18 lakh to Rs 6 lakh a year, I can finally afford therapy within my salary’: Delhi HC allows Natco to manufacture Roche’s rare disease drug
10 Oct 2025 13:28 GMT
… international pharmaceutical giant Roche’s Risdiplam. The medicine can … relief works for continued treatment
Although not entirely affordable … permit to manufacture Nexavar, a cancer drug made by German … effective, there were no trials, there were no approvals …
-
<![CDATA[Applying Desmoid Tumor Treatment Strategies and Data in Practice]]>
23 Sep 2025 01:09 GMT
… key clinical trials of systemic therapies like sorafenib (Nexavar) and … requires treatment, then treat.
Can you discuss the trials that … of Medicine in 2018 was the Alliance A091105 trial [NCT02066181 … the activity of this drug in progressive, symptomatic …
-
<![CDATA[Exploring Differences in Survival With Lenvatinib in Recent HCC Trials]]>
17 Sep 2025 21:22 GMT
… Reserve University School of Medicine, and director of … in the recent CheckMate 9DW trial (NCT04039607) investigating nivolumab … and sorafenib (Nexavar), whereas contemporary trials were run when … an approved first-line treatment in unresectable HCC.
…
-
Mint Explainer | First Dr Reddy’s, now Natco: Why Indian drugmakers are suing Novo Nordisk
25 Aug 2025 13:10 GMT
… launch the drug next year. They include Sun Pharmaceutical Industries, … have leveraged their diabetes-treatment leadership to grab the … kidney and lung cancer drug Nexavar or Roche’s Risdiplam … a weight-management drug than a lifesaving medicine, the sheer …
-
FDA approves expanded indication for Teva’s Ajovy
18 Aug 2025 20:11 GMT
… FDA approval, Ajovy now offers younger patients a new treatment … Neurologic Institute. “Having an FDA-approved treatment like Ajovy offers an … targeted approach to preventive treatment for episodic migraine that … : Teva rolls out generic Nexavar tablets]
-
Assessing Tivozanib Efficacy in Metastatic RCC Treatment
05 Aug 2025 01:47 GMT
… in the Department of Medical Oncology & Therapeutics … tivozanib to sorafenib [Nexavar], and at the time … ;www.fda.gov/drugs/;resources-information-approved-drugs/fda-approves- … of second line (2L) treatment with tivozanib (tivo) as …
-
Lipid-Lowering Effects Discovered in FDA-Approved Drugs Using Machine Learning
09 Aug 2025 16:36 GMT
… before and after medication, 4 drugs—argatroban (Acova), … including sorafenib (Nexavar; Bayer), prasterone (Intrarosa; Cosette Pharmaceuticals), and regorafenib … results of this trial provide a multitude … A Meta-Analysis of Statin Trials. JACC. 2014;64( …